These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 5627165)
1. [Clinical experiences with SP-I]. Furue H; Koizumi H; Nishi I; Hattori T; Yokoyama T Gan No Rinsho; 1967 Sep; 13(9):658-62. PubMed ID: 5627165 [No Abstract] [Full Text] [Related]
2. [Treatment of malignant tumors with SP-I/SP-G Sandoz (Proresid)]. Bîrzu I Ther Umsch; 1966 Dec; 23(12):522-7. PubMed ID: 5980440 [No Abstract] [Full Text] [Related]
3. [5-year results of combined treatment with the cobalt bomb and the cytostatic preparation SP-G and SP-I (Sandoz)]. Hubacher O Dtsch Med Wochenschr; 1965 Nov; 90(48):2145-9. PubMed ID: 5844793 [No Abstract] [Full Text] [Related]
4. [Therapeutic effects of podophyllin derivatives on malignant neoplasms]. Diefenthaeler E; Herter NT Hospital (Rio J); 1968 Jan; 73(1):183-95. PubMed ID: 5308491 [No Abstract] [Full Text] [Related]
5. [Cytostatic therapy of metastatic and advanced malignant tumors of the ENT region with podophyllin derivatives (SPI-SPG)]. Lipozencić M; Padovan I Rad Med Fak Zagrebu; 1965; 13(1):57-67. PubMed ID: 5871944 [No Abstract] [Full Text] [Related]
6. [Favourable response of advanced ovarian cancer to treatment with a podophyllin derivative (SP-I and SP-G)]. Tomin R Srp Arh Celok Lek; 1965 Oct; 93(10):973-9. PubMed ID: 5872509 [No Abstract] [Full Text] [Related]
7. [Studies with Proresid (SP-I) in various transplantable tumors]. Cerletti A; Stähelin H; Schoch J Med Klin; 1966 Jul; 61(30):1192-4. PubMed ID: 5993141 [No Abstract] [Full Text] [Related]
8. SPI and SPG in the treatment of advanced malignant lesions. Grewal TS; Samual KC; Sachdev DL; Rastogi DC Int Surg; 1967 Oct; 48(4):360-7. PubMed ID: 6050546 [No Abstract] [Full Text] [Related]
9. [Clinical findings in podophyllotoxin derivatives (SP-I-SP-G) in malignant tumors]. Ohara H; Noto J; Kihara A; Noguchi H; Ishii Y Gan No Rinsho; 1968 Feb; 14(2):96-100. PubMed ID: 5244790 [No Abstract] [Full Text] [Related]
10. [Experiences with the cytostatic podophyllin therapy]. Halama J Munch Med Wochenschr; 1967 Feb; 108(7):378-81. PubMed ID: 4862314 [No Abstract] [Full Text] [Related]
11. [Clinical use of podophyllinic acid ethylhydrazide (SP-I) and podophyllotoxin-beta-o-benzyliden-glucoside (SP-G) in malignant urologic tumors]. Aso Y; Hoshi Y; Okada K; Koiso K; Murahashi I Gan No Rinsho; 1969 May; 15(5):453-7. PubMed ID: 5387577 [No Abstract] [Full Text] [Related]
12. [Considerations on the use of Proresid (SPI-SPG Sandoz) as an adjuvant in the treatment of tumors (preliminart communication)]. Motti VJ Hospital (Rio J); 1968 Oct; 74(4):1377-88. PubMed ID: 5304166 [No Abstract] [Full Text] [Related]
13. [Experience in the therapeutic use of podophyllin in some dermatoses]. Popov IS; Chepyzhenko VV Vrach Delo; 1966 Jan; 1():150-1. PubMed ID: 5974047 [No Abstract] [Full Text] [Related]
14. [New possibilities in testing resistance of human carcinoma tissue to cytostatic agents in vivo]. Heckmann U Dtsch Med Wochenschr; 1967 May; 92(20):932-5 passim. PubMed ID: 4960735 [No Abstract] [Full Text] [Related]
15. Treatment of juvenile papilloma of the larynx with resin of podophyllin. Fabritius HF Acta Otolaryngol; 1966 Jun; ():Suppl 224:467+. PubMed ID: 5992700 [No Abstract] [Full Text] [Related]
16. [Evaluation of immunosuppressive therapy with podophyllin derivatives in the treatment of primary chronic polyarthritis]. Szántó L Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:154. PubMed ID: 5402573 [No Abstract] [Full Text] [Related]
17. [Clinical observations and results of the treatment of malignant tumors with podophyllim derivatives Sp-I and Sp-G]. Tomov V; Popov G; Stoianov E Khirurgiia (Sofiia); 1965; 18(6):623-32. PubMed ID: 5886870 [No Abstract] [Full Text] [Related]
18. [Studies with Proresid (SP-I) in various innoculation tumors]. Osswald H; Schmähl D Med Klin; 1966 Apr; 61(17):681-4. PubMed ID: 5995181 [No Abstract] [Full Text] [Related]
19. [The association of podophyllum derivatives and cyclophosphamide in the palliative therapy of female pelvic neoplasms]. Varianti G Cancro; 1965; 18(6):526-41. PubMed ID: 4162232 [No Abstract] [Full Text] [Related]
20. Podophyllin-salicylic acid solution in treatment of basal cell carcinomas. Nelson LM Arch Dermatol; 1966 Apr; 93(4):457-9. PubMed ID: 5862640 [No Abstract] [Full Text] [Related] [Next] [New Search]